Researchers at the University of Wisconsin-Madison in a study funded by USDA and NIH, discovered that not only was one of the carrier proteins for vitamin A, retinol-binding protein (RBP), elevated in obese individuals compared to leaner controls, but some of it was not attached to retinol, the main circulating form of the vitamin.
RBP that is not bound to vitamin A is called apo-RBP by vitamin A scientists. Their study will appear in the October 08 issue of Experimental Biology and Medicine.
The research team led by Sherry Tanumihardjo, an associate professor of Nutritional Sciences, originally was interested in determining the degree of hypervitaminosis A in the cohort for preliminary data on excessive liver storage of the vitamin. Her graduate student, Jordan Mills, was interested in determining the retinol-binding protein concentrations. While the degree of hypervitaminosis A was remarkable at 4% prevalence for the obese cohort, the relationship of retinol to RBP was a more interesting discovery. The retinol to RBP ratio (retinol:RBP) was significantly lower in the obese subjects than nonobese subjects. This was attributable to more RBP circulating in the serum not bound to vitamin A. RBP was strongly associated with vitamin A in both groups, but more so in the nonobese individuals.
"A series of studies in mice and humans revealed a strong relationship between serum RBP and obesity-induced insulin resistance. While some studies validated these original observations of elevated RBP in obesity and insulin resistance in humans, others have not. Often lacking in these publications are data for serum retinol, arguably RBP's most important physiological companion, representing a possible explanation for conflicting results," said Mills. Tanumihardjo added, "Our results further the understanding of the relationship of retinol, RBP, and BMI and suggest that apo-RBP should be evaluated. Retinol:RBP may add new insights and be a better clinical diagnostic for potential insulin resistance than RBP alone." The authors say, "This elevated serum apo-RBP may be adipose-derived and it is unknown whether it is a direct contributor to insulin resistance in obese individuals. Alternatively, apo-RBP from adipose may transport an unidentified ligand that is responsible for mediating insulin signaling." Further research is needed to determine whether apo-RBP is bound to some other compound in circulation. Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "this interesting study, led by Dr. Tanumihardjo, opens the door to the determination of the role of apo-RBP in insulin resistance in obese individuals. This will be an important issue for those working on type 2 diabetes".
Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit www.sebm.org.
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine